Evidence map›Paper›PMID 38751240›Full record

ReviewInternational journal of technology assessment in health care2024

An operationalization framework for lifecycle health technology assessment: a Health Technology Assessment International Global Policy Forum Task Force report.

Franz B Pichler, Meindert Boysen, Nicole Mittmann, Ramiro Gilardino, Andrew Bruce, Kenneth Bond, Rick A Vreman, Nathalie Largeron, Judit Banhazi, Daniel A Ollendorf and 3 more

Abstract readReview
In one paragraph

Review in International journal of technology assessment in health care, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Action Plan to Better Approximate Reality in Cost-Effectiveness Analyses.Applied health economics and health policy · 2026
    Article
  2. A life-cycle approach to digital health technology assessment.International journal of technology assessment in health care · 2026
    Review
  3. Beyond efficiency: reimagining health technology assessment in the age of artificial intelligence.International journal of technology assessment in health care · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Franz B PichlerConfluence Health Consulting, Sydney, NSW, Australia.ORCID https://orcid.org/0009-0005-1765-8487
Meindert BoysenNational Institute for Health and Care Excellence (NICE), London, UK.
Nicole MittmannCanadian Agency for Drugs and Technologies in Healthcare, Ottawa, ON, Canada.
Ramiro GilardinoMSD, Zurich, Switzerland.ORCID https://orcid.org/0000-0002-9238-7729
Andrew BruceAmgen, Sydney, NSW, Australia.
Kenneth BondInstitute of Health Economics, Edmonton, AB, Canada.ORCID https://orcid.org/0000-0002-7620-9375
Rick A VremanRoche, Utrecht, Netherlands.
Nathalie LargeronSanofi, Paris, France.
Judit BanhaziMenarini, Zurich, Switzerland.
Daniel A OllendorfTufts Medical Center, Institute for Clinical Research and Health Policy Studies, Boston, MA, USA.
Mohit JainBioMarin, London, UK.
Sheela UpadhyayaLife Sciences Consultant, London, UK.
Wim G GoettschZorginstituut Nederland (ZIN), Utrecht, Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Operationalization guidance is needed to support health technology assessment (HTA) bodies considering implementing lifecycle HTA (LC-HTA) approaches. The 2022 Health Technology Assessment International (HTAi) Global Policy Forum (GPF) established a Task Force to develop a position paper on LC-HTA. In its first paper, the Task Force established a definition and framework for LC-HTA in order to tailor it to specific decision problems. This second paper focused on the provision of practical operational guidance to implement LC-HTA. Detailed descriptions of the three LC-HTA operational steps are provided (defining the decision problem, sequencing of HTA activities, and developing optimization criteria) and accompanied by worked examples and an operationalization checklist with 20 different questions for HTA bodies to consider when developing an LC-HTA approach. The questions were designed to be applicable across different types of HTA and scenarios, and require adaptation to local jurisdictions, remits, and context.

Indexed as

Advisory CommitteesTechnology Assessment, BiomedicalDecision MakingHealth PolicyHumanschecklistcriteriaexamplesguidancelifecycleOperationalizationpracticalsequencing

Identifiers

PMID38751240
PMCPMC11569903

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.